RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer-Reference-Cited by-同舟云学术

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer

Published:2013-03-12 Issue:2 Volume:138 Page:427-435
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Moreno-Aspitia Alvaro,Dueck Amylou C.,Ghanem-Cañete Ismael,Patel Tejal,Dakhil Shaker,Johnson David,Franco Sandra,Kahanic Stephen,Colon-Otero Gerardo,Tenner Kathleen S.,Rodeheffer Richard,McCullough Ann E.,Jenkins Robert B.,Palmieri Frances M.,Northfelt Donald,Perez Edith A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-013-2469-2.pdf

Reference32 articles.

1. Perez EA, Roche PC, Jenkins RB, Reynolds CA, Halling KC, Ingle JN, Wold LE (2002) HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. Mayo Clin Proc 77(2):148–154

2. Coussens L, Yang-Feng TL, Liao YC, Chen E, Gray A, McGrath J, Seeburg PH, Libermann TA, Schlessinger J, Francke U et al (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230(4730):1132–1139

3. Ross JR (2009) Breast cancer biomarkers and HER2 testing after 10 years of ani-HER2 therapy. Drug News perspect 22(2):93–106

4. Yaziji H, Goldstein LC, Barry TS, Werling R, Hwang H, Ellis GK, Gralow JR, Livingston RB, Gown AM (2004) HER-2 testing in breast cancer using parallel tissue-based methods. JAMA 291(16):1972–1977

5. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235(4785):177–182

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New anthraquinone drugs and their anticancer activities: Cytotoxicity, DFT, docking and ADMET properties;Results in Chemistry;2023-12

2. Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy;Molecules;2020-12-02

3. N083E (Alliance): long-term outcomes of patients treated in a pilot phase II study of docetaxel, carboplatin, trastuzumab, and lapatinib as adjuvant therapy for early-stage HER2-positive breast cancer;Breast Cancer Research and Treatment;2020-06-05

4. Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer;South Asian Journal of Cancer;2018-04

5. Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine;Genomics, Proteomics & Bioinformatics;2017-08